future of aggressive lymphoma treatment: a shift towards chemo-free regimens
Published 6 years ago • 123 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
5:21
chemo-free regimens in lymphoma
-
1:47
advances in hodgkin lymphoma treatment: moving away from abvd and beacopp
-
1:30
the use of targeted drug therapy for aggressive lymphoma
-
1:21
the future of lymphoma treatment – combining new therapies with molecular diagnosis
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
1:36
the future of frontline treatment in all: immunotherapy
-
1:58
incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
-
2:14
updates on the smart stop trial: the potential for a chemo-free regimen in the frontline for dlbcl
-
2:39
the future of immunotherapy for the treatment of all
-
1:17
the importance of risk-adapted therapies in hodgkin lymphoma
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:25
the future of car-t for the treatment of lymphoma
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:18
the role of cellular immunotherapies in the future treatment of hl